FHIR IG analytics| Package | de.medizininformatikinitiative.kerndatensatz.onkologie |
| Resource Type | ValueSet |
| Id | ValueSet-mii-vs-onko-systemische-therapie-substanzen-2021.json |
| FHIR Version | R4 |
| Source | https://medizininformatik-initiative.github.io/kerndatensatzmodul-onkologie/2027.0.0-ballot.1/ValueSet-mii-vs-onko-systemische-therapie-substanzen-2021.html |
| URL | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-systemische-therapie-substanzen-2021 |
| Version | 2027.0.0-ballot.1 |
| Status | active |
| Date | 2026-09-15T06:26:59+00:00 |
| Name | MII_VS_Onko_Systemische_Therapie_Substanzen_2021 |
| Title | MII VS Onkologie Systemische Therapie Substanzen ATC 2021 |
| Realm | de |
| Description | ATC-Codes für Substanzen der systemischen Therapie, validiert gegen ATC-DE Version 2021. Für historische Datenvalidierung. |
| ConceptMap | ||
| de.medizininformatikinitiative.kerndatensatz.onkologie#2027.0.0-ballot.1 | mii-cm-onko-atc-transitions-2021 | MII CM Onko ATC Code Changes 2020 to 2021 |
| de.medizininformatikinitiative.kerndatensatz.onkologie#2027.0.0-ballot.1 | mii-cm-onko-atc-transitions-2022 | MII CM Onko ATC Code Changes 2021 to 2022 |
| CodeSystem | ||
| de.fhir.terminologie-basis#1.0.0-alpha1 | atc | ATC |
Note: links and images are rebased to the (stated) source
English
Generated Narrative: ValueSet mii-vs-onko-systemische-therapie-substanzen-2021
Profiles: Shareable ValueSet, CRMI Shareable ValueSet, CRMI Publishable ValueSet, CRMI Computable ValueSet
http://fhir.de/CodeSystem/bfarm/atc version 📍2021| Code | Display | MII CM Onko ATC Code Changes 2021 to 2022 |
| L02BX01 | Abarelix | |
| L04AA24 | Abatacept | |
| L01EF03 | Abemaciclib | |
| L04AA22 | Abetimus | |
| L02BX03 | Abirateron | |
| L01EL02 | Acalabrutinib | |
| L01DB04 | Aclarubicin | |
| L04AB04 | Adalimumab | |
| L01EB03 | Afatinib | |
| L04AB03 | Afelimomab | |
| L01XX44 | Aflibercept | |
| L03AC01 | Aldesleukin | |
| L01ED03 | Alectinib | |
| L04AA15 | Alefacept | |
| L04AA34 | Alemtuzumab | |
| M05BA04 | Alendronsäure | |
| L01XF02 | Alitretinoin | |
| L01EM03 | Alpelisib | |
| L01XX03 | Altretamin | |
| V03AM01 | Amilomer | |
| L02BG01 | Aminoglutethimid | |
| L01XD04 | Aminolevulinsäure | |
| L01DB10 | Amrubicin | |
| L01XX01 | Amsacrin | |
| L01XX35 | Anagrelid | |
| L04AC03 | Anakinra | |
| L02BG03 | Anastrozol | |
| L04AA04 | Antithymozytäres Immunglobulin (Kaninchen) | |
| L02BB05 | Apalutamid | |
| L01XX27 | Arsentrioxid | |
| P01BE03 | Artesunat | |
| L01XX02 | Asparaginase | |
| L01XC32 | Atezolizumab | ~L01FF05(Reklassifizierung zu PD-1-/PD-L1-Inhibitoren) |
| L01EX18 | Avapritinib | |
| L01XC31 | Avelumab | ~L01FF04(Reklassifizierung zu PD-1-/PD-L1-Inhibitoren) |
| L01XX70 | Axicabtagen Ciloleucel | |
| L01EK01 | Axitinib | |
| L01BC07 | Azacitidin | |
| L04AX01 | Azathioprin | |
| L04AC02 | Basiliximab | |
| L03AX03 | BCG-Impfstoff | |
| L04AA28 | Belatacept | |
| L04AA26 | Belimumab | |
| L01XH04 | Belinostat | |
| L01AA09 | Bendamustin | |
| L01XC07 | Bevacizumab | ~L01FG01(Reklassifizierung zu VEGF-/VEGFR-Inhibitoren) |
| L01XF03 | Bexaroten | |
| L02BB03 | Bicalutamid | |
| L01EE03 | Binimetinib | |
| L01DC01 | Bleomycin | |
| L01XC19 | Blinatumomab | ~L01FX07(Reklassifizierung zu andere monoklonale Antikörper) |
| L01XG01 | Bortezomib | |
| L01EA04 | Bosutinib | |
| L01XC12 | Brentuximab vedotin | ~L01FX05(Reklassifizierung zu andere monoklonale Antikörper) |
| L04AC09 | Briakinumab | |
| L01ED04 | Brigatinib | |
| N04BC01 | Bromocriptin | |
| L02AE01 | Buserelin | |
| L01AB01 | Busulfan | |
| L01CD04 | Cabazitaxel | |
| N04BC06 | Cabergolin | |
| L01EX07 | Cabozantinib | |
| V03AF04 | Calciumlevofolinat | |
| L04AC08 | Canakinumab | |
| L01BC06 | Capecitabin | |
| L01EX17 | Capmatinib | |
| L01XA02 | Carboplatin | |
| L01AC03 | Carboquon | |
| L01XG02 | Carfilzomib | |
| L01BC04 | Carmofur | |
| L01AD01 | Carmustin | |
| L01ED02 | Ceritinib | |
| L04AB05 | Certolizumab pegol | |
| H01CC02 | Cetrorelix | |
| L01XC06 | Cetuximab | ~L01FE01(Reklassifizierung zu EGFR-Inhibitoren) |
| L01AA02 | Chlorambucil | |
| G03DB06 | Chlormadinon | |
| L01AA05 | Chlormethin | |
| L04AD01 | Ciclosporin | |
| L01XA01 | Cisplatin | |
| L01BB04 | Cladribin | |
| M05BA02 | Clodronsäure | |
| L01BB06 | Clofarabin | |
| L01EE02 | Cobimetinib | |
| L01EM02 | Copanlisib | |
| L01ED01 | Crizotinib | |
| L01AA01 | Cyclophosphamid | |
| G03HA01 | Cyproteron | |
| L01BC01 | Cytarabin | |
| L01XY01 | Cytarabin und Daunorubicin | |
| L01EC02 | Dabrafenib | |
| L01AX04 | Dacarbazin | |
| L04AC01 | Daclizumab | |
| L01EB07 | Dacomitinib | |
| L01DA01 | Dactinomycin | |
| L01XC24 | Daratumumab | ~L01FC01(Reklassifizierung zu CD38-Inhibitoren) |
| B03XA02 | Darbepoetin alfa | |
| L02BB06 | Darolutamid | |
| L01EA02 | Dasatinib | |
| L01DB02 | Daunorubicin | |
| L01BC08 | Decitabin | |
| L02BX02 | Degarelix | |
| L01CC01 | Demecolcin | |
| L01XX29 | Denileukindiftitox | |
| M05BX04 | Denosumab | |
| H02AB02 | Dexamethason | |
| L01CD02 | Docetaxel | |
| L01DB01 | Doxorubicin | |
| L01XC28 | Durvalumab | ~L01FF03(Reklassifizierung zu PD-1-/PD-L1-Inhibitoren) |
| G04CB02 | Dutasterid | |
| L01EM04 | Duvelisib | |
| L04AA25 | Eculizumab | |
| L04AA21 | Efalizumab | |
| L01XD06 | Efaproxiral | |
| B02BX05 | Eltrombopag | |
| L01XX59 | Enasidenib | |
| L01EC03 | Encorafenib | |
| L01EX14 | Entrectinib | |
| L02BB04 | Enzalutamid | |
| L01DB03 | Epirubicin | |
| L01XX41 | Eribulin | |
| L01EB02 | Erlotinib | |
| B03XA01 | Erythropoietin | |
| L01XX11 | Estramustin | |
| L04AB01 | Etanercept | |
| M05BA01 | Etidronsäure | |
| L01AG01 | Etoglucid | |
| L01CB01 | Etoposid | |
| L01EG02 | Everolimus | |
| L02BG06 | Exemestan | |
| L01EJ02 | Fedratinib | |
| L03AA02 | Filgrastim | |
| G04CB01 | Finasterid | |
| L04AA27 | Fingolimod | |
| L01BC09 | Floxuridin | |
| L01BB05 | Fludarabin | |
| L01BC02 | Fluorouracil | |
| L01BC52 | Fluorouracil, Kombinationen | |
| L02BB01 | Flutamid | |
| V03AF03 | Calciumfolinat | |
| L02BG02 | Formestan | |
| L02AA04 | Fosfestrol | |
| B02BX09 | Fostamatinib | |
| L01AD05 | Fotemustin | |
| L02BA03 | Fulvestrant | |
| L01EB01 | Gefitinib | |
| L01BC05 | Gemcitabin | |
| L02AB03 | Gestonoron | |
| L01EX13 | Gilteritinib | |
| L01XJ03 | Glasdegib | |
| L04AB06 | Golimumab | |
| H01CA01 | Gonadorelin | |
| L02AE03 | Goserelin | |
| L04AA19 | Gusperimus | |
| L03AX14 | Histamindihydrochlorid | |
| L02AE05 | Histrelin | |
| L01XX05 | Hydroxycarbamid | |
| M05BA06 | Ibandronsäure | |
| V10XX02 | (90Y)Ibritumomabtiuxetan | |
| L01EL01 | Ibrutinib | |
| L01DB06 | Idarubicin | |
| L01EM01 | Idelalisib | |
| L01AA06 | Ifosfamid | |
| L01EA01 | Imatinib | |
| D06BB10 | Imiquimod | |
| L04AB02 | Infliximab | |
| D06BX02 | Ingenolmebutat | |
| L01XC26 | Inotuzumab ozogamicin | ~L01FB01(Reklassifizierung zu CD22-Inhibitoren) |
| L03AB01 | Interferon alfa, natürlich | |
| L03AB04 | Interferon alfa-2a | |
| L03AB05 | Interferon alfa-2b | |
| L03AB18 | Interferon gamma-1b | |
| L01XC11 | Ipilimumab | ~L01FX04(Reklassifizierung zu andere monoklonale Antikörper) |
| L01CE02 | Irinotecan | |
| L01XX62 | Ivosidenib | |
| L01DC04 | Ixabepilon | |
| L01XG03 | Ixazomib | |
| H02CA03 | Ketoconazol | |
| H01CB03 | Lanreotid | |
| L01EH01 | Lapatinib | |
| L01EX12 | Larotrectinib | |
| L04AA13 | Leflunomid | |
| L04AX04 | Lenalidomid | |
| L03AA10 | Lenograstim | |
| L01EX08 | Lenvatinib | |
| L02BG04 | Letrozol | |
| L02AE02 | Leuprorelin | |
| L03AA14 | Lipegfilgrastim | |
| L01AD02 | Lomustin | |
| L01XX07 | Lonidamin | |
| L01ED05 | Lorlatinib | |
| B03XA06 | Luspatercept | |
| G03DC03 | Lynestrenol | |
| L01AB03 | Mannosulfan | |
| J05AX09 | Maraviroc | |
| L01XX10 | Masoprocol | |
| L02AB02 | Medroxyprogesteron | |
| L02AB01 | Megestrol | |
| L01AA03 | Melphalan | |
| R03DX09 | Mepolizumab | |
| L01BB02 | Mercaptopurin | |
| V03AF01 | Mesna | |
| N07BC02 | Methadon | |
| L01BA01 | Methotrexat | |
| L01XD10 | Methoxsalen | |
| B03XA03 | Methoxy-Polyethylenglycol-Epoetin beta | |
| L01XD03 | Methylaminolevulinat | |
| H02AB04 | Methylprednisolon | |
| L01EX10 | Midostaurin | |
| L03AX15 | Mifamurtid | |
| L01XX09 | Miltefosin | |
| L01CH01 | Mistelkraut | |
| L01CP01 | Mistelkraut | |
| L01AX01 | Mitobronitol | |
| L01XX16 | Mitoguazon | |
| L01DC03 | Mitomycin | |
| L01XX23 | Mitotan | |
| L01DB07 | Mitoxantron | |
| L03AA03 | Molgramostim | |
| L04AA02 | Muromonab-CD3 | |
| L04AA06 | Mycophenolsäure | |
| L04AA23 | Natalizumab | |
| V03AF10 | Natriumlevofolinat | |
| L01BB07 | Nelarabin | |
| L01EH02 | Neratinib | |
| L01EA03 | Nilotinib | |
| L02BB02 | Nilutamid | |
| L01AD06 | Nimustin | |
| L01EX09 | Nintedanib | |
| L01XK02 | Niraparib | |
| L01XC17 | Nivolumab | ~L01FF01(Reklassifizierung zu PD-1-/PD-L1-Inhibitoren) |
| L01XC15 | Obinutuzumab | ~L01FA03(Reklassifizierung zu CD20-Inhibitoren) |
| L01XX36 | Oblimersen | |
| H01CB02 | Octreotid | |
| L01XK01 | Olaparib | |
| L01XC27 | Olaratumab | ~L01FX10(Reklassifizierung zu andere monoklonale Antikörper) |
| L01XX40 | Omacetaxinmepesuccinat | |
| L03AC02 | Oprelvekin | |
| L01EB04 | Osimertinib | |
| L01XA03 | Oxaliplatin | |
| L01CD01 | Paclitaxel | |
| L01CD03 | Paclitaxelpoliglumex | |
| L01EF01 | Palbociclib | |
| V03AF08 | Palifermin | |
| M05BA03 | Pamidronsäure | |
| L01XC08 | Panitumumab | ~L01FE02(Reklassifizierung zu EGFR-Inhibitoren) |
| L01XH03 | Panobinostat | |
| L01EX03 | Pazopanib | |
| L01XX24 | Pegaspargase | |
| L03AA13 | Pegfilgrastim | |
| L03AB11 | Peginterferon alfa-2a | |
| L03AB10 | Peginterferon alfa-2b | |
| L01XC18 | Pembrolizumab | ~L01FF02(Reklassifizierung zu PD-1-/PD-L1-Inhibitoren) |
| L01BA04 | Pemetrexed | |
| L01XX08 | Pentostatin | |
| L01XC13 | Pertuzumab | ~L01FD02(Reklassifizierung zu HER2-Inhibitoren) |
| L01AX02 | Pipobroman | |
| L01DB08 | Pirarubicin | |
| L01DB11 | Pixantron | |
| V03AX10 | Placebo | |
| L03AX16 | Plerixafor | |
| L01DC02 | Plicamycin | |
| L03AX08 | Poly ICLC | |
| L02AA02 | Polyestradiolphosphat | |
| L01XA05 | Polyplatillen | |
| L04AX06 | Pomalidomid | |
| L01EA05 | Ponatinib | |
| L01XD01 | Porfimer natrium | |
| L01BA05 | Pralatrexat | |
| D07AC18 | Prednicarbat | |
| L01AA08 | Prednimustin | |
| H02AB06 | Prednisolon | |
| H02AB07 | Prednison | |
| L01XB01 | Procarbazin | |
| D05AD | Psoralene zur topischen Anwendung | |
| D05BA | Psoralene zur systemischen Anwendung | |
| L01EX11 | Quizartinib | |
| G03XC01 | Raloxifen | |
| L01BA03 | Raltitrexed | |
| L01XC21 | Ramucirumab | ~L01FG02(Reklassifizierung zu VEGF-/VEGFR-Inhibitoren) |
| L01AD07 | Ranimustin | |
| L01EX05 | Regorafenib | |
| L01EF02 | Ribociclib | |
| L04AC04 | Rilonacept | |
| L01EX19 | Ripretinib | |
| M05BA07 | Risedronsäure | |
| L01XC02 | Rituximab | ~L01FA01(Reklassifizierung zu CD20-Inhibitoren) |
| L01XH02 | Romidepsin | |
| B02BX04 | Romiplostim | |
| L03AB15 | Ropeginterferon alfa-2b | |
| L01XK03 | Rucaparib | |
| L01EJ01 | Ruxolitinib | |
| L01XA04 | Satraplatin | |
| L01XX66 | Selinexor | |
| L01EE04 | Selumetinib | |
| L01AD03 | Semustin | |
| L04AC11 | Siltuximab | |
| L04AA10 | Sirolimus | |
| H01CB01 | Somatostatin | |
| L01XJ02 | Sonidegib | |
| L01EX02 | Sorafenib | |
| L01AD04 | Streptozocin | |
| L01EX01 | Sunitinib | |
| L04AD02 | Tacrolimus | |
| L01XX67 | Tagraxofusp | |
| L01XK04 | Talazoparib | |
| L01XX51 | Talimogen laherparepvec | |
| L02BA01 | Tamoxifen | |
| L03AX11 | Tasonermin | |
| L01BC53 | Tegafur, Kombinationen | |
| L01BC63 | Tegafur und Uracil | |
| L01BC73 | Tegafur, Gimeracil und Oteracil | |
| L01XD05 | Temoporfin | |
| L01AX03 | Temozolomid | |
| L01EG01 | Temsirolimus | |
| L01CB02 | Teniposid | |
| L01EX21 | Tepotinib | |
| L04AX02 | Thalidomid | |
| L01AC01 | Thiotepa | |
| L01XX18 | Tiazofurin | |
| M05BA05 | Tiludronsäure | |
| L01BB03 | Tioguanin | |
| L01XX71 | Tisagenlecleucel | |
| L01EK03 | Tivozanib | |
| L04AC07 | Tocilizumab | |
| L01CE01 | Topotecan | |
| L02BA02 | Toremifen | |
| V10XA53 | Tositumomab/(131I)Iodtositumomab | |
| L01CX01 | Trabectedin | |
| L01EE01 | Trametinib | |
| L01XC03 | Trastuzumab | ~L01FD01(Reklassifizierung zu HER2-Inhibitoren) |
| L01XC14 | Trastuzumab emtansin | ~L01FD03(Reklassifizierung zu HER2-Inhibitoren) |
| L01AB02 | Treosulfan | |
| L01XF01 | Tretinoin | |
| L01AC02 | Triaziquon | |
| L01BC59 | Trifluridin, Kombinationen | |
| L02AE04 | Triptorelin | |
| L01AA07 | Trofosfamid | |
| L01EH03 | Tucatinib | |
| L01AD08 | Uramustin | |
| N03AG01 | Valproinsäure | |
| L01DB09 | Valrubicin | |
| L01EX04 | Vandetanib | |
| L01XK05 | Veliparib | |
| L01EC01 | Vemurafenib | |
| L01XX52 | Venetoclax | |
| L01CA01 | Vinblastin | |
| L01CA02 | Vincristin | |
| L01CA03 | Vindesin | |
| L01CA05 | Vinflunin | |
| L01CA04 | Vinorelbin | |
| L01XJ01 | Vismodegib | |
| L04AD03 | Voclosporin | |
| L01XH01 | Vorinostat | |
| L02BG05 | Vorozol | |
| L01XX53 | Vosaroxin | |
| L01EL03 | Zanubrutinib | |
| M05BA08 | Zoledronsäure | |
| L01DB05 | Zorubicin |
German
Generated Narrative: ValueSet mii-vs-onko-systemische-therapie-substanzen-2021
Profiles: Shareable ValueSet, CRMI Shareable ValueSet, CRMI Publishable ValueSet, CRMI Computable ValueSet
http://fhir.de/CodeSystem/bfarm/atc version 📍2021| Code | Display | MII CM Onko ATC Code Changes 2021 to 2022 |
| L02BX01 | Abarelix | |
| L04AA24 | Abatacept | |
| L01EF03 | Abemaciclib | |
| L04AA22 | Abetimus | |
| L02BX03 | Abirateron | |
| L01EL02 | Acalabrutinib | |
| L01DB04 | Aclarubicin | |
| L04AB04 | Adalimumab | |
| L01EB03 | Afatinib | |
| L04AB03 | Afelimomab | |
| L01XX44 | Aflibercept | |
| L03AC01 | Aldesleukin | |
| L01ED03 | Alectinib | |
| L04AA15 | Alefacept | |
| L04AA34 | Alemtuzumab | |
| M05BA04 | Alendronsäure | |
| L01XF02 | Alitretinoin | |
| L01EM03 | Alpelisib | |
| L01XX03 | Altretamin | |
| V03AM01 | Amilomer | |
| L02BG01 | Aminoglutethimid | |
| L01XD04 | Aminolevulinsäure | |
| L01DB10 | Amrubicin | |
| L01XX01 | Amsacrin | |
| L01XX35 | Anagrelid | |
| L04AC03 | Anakinra | |
| L02BG03 | Anastrozol | |
| L04AA04 | Antithymozytäres Immunglobulin (Kaninchen) | |
| L02BB05 | Apalutamid | |
| L01XX27 | Arsentrioxid | |
| P01BE03 | Artesunat | |
| L01XX02 | Asparaginase | |
| L01XC32 | Atezolizumab | ~L01FF05(Reklassifizierung zu PD-1-/PD-L1-Inhibitoren) |
| L01EX18 | Avapritinib | |
| L01XC31 | Avelumab | ~L01FF04(Reklassifizierung zu PD-1-/PD-L1-Inhibitoren) |
| L01XX70 | Axicabtagen Ciloleucel | |
| L01EK01 | Axitinib | |
| L01BC07 | Azacitidin | |
| L04AX01 | Azathioprin | |
| L04AC02 | Basiliximab | |
| L03AX03 | BCG-Impfstoff | |
| L04AA28 | Belatacept | |
| L04AA26 | Belimumab | |
| L01XH04 | Belinostat | |
| L01AA09 | Bendamustin | |
| L01XC07 | Bevacizumab | ~L01FG01(Reklassifizierung zu VEGF-/VEGFR-Inhibitoren) |
| L01XF03 | Bexaroten | |
| L02BB03 | Bicalutamid | |
| L01EE03 | Binimetinib | |
| L01DC01 | Bleomycin | |
| L01XC19 | Blinatumomab | ~L01FX07(Reklassifizierung zu andere monoklonale Antikörper) |
| L01XG01 | Bortezomib | |
| L01EA04 | Bosutinib | |
| L01XC12 | Brentuximab vedotin | ~L01FX05(Reklassifizierung zu andere monoklonale Antikörper) |
| L04AC09 | Briakinumab | |
| L01ED04 | Brigatinib | |
| N04BC01 | Bromocriptin | |
| L02AE01 | Buserelin | |
| L01AB01 | Busulfan | |
| L01CD04 | Cabazitaxel | |
| N04BC06 | Cabergolin | |
| L01EX07 | Cabozantinib | |
| V03AF04 | Calciumlevofolinat | |
| L04AC08 | Canakinumab | |
| L01BC06 | Capecitabin | |
| L01EX17 | Capmatinib | |
| L01XA02 | Carboplatin | |
| L01AC03 | Carboquon | |
| L01XG02 | Carfilzomib | |
| L01BC04 | Carmofur | |
| L01AD01 | Carmustin | |
| L01ED02 | Ceritinib | |
| L04AB05 | Certolizumab pegol | |
| H01CC02 | Cetrorelix | |
| L01XC06 | Cetuximab | ~L01FE01(Reklassifizierung zu EGFR-Inhibitoren) |
| L01AA02 | Chlorambucil | |
| G03DB06 | Chlormadinon | |
| L01AA05 | Chlormethin | |
| L04AD01 | Ciclosporin | |
| L01XA01 | Cisplatin | |
| L01BB04 | Cladribin | |
| M05BA02 | Clodronsäure | |
| L01BB06 | Clofarabin | |
| L01EE02 | Cobimetinib | |
| L01EM02 | Copanlisib | |
| L01ED01 | Crizotinib | |
| L01AA01 | Cyclophosphamid | |
| G03HA01 | Cyproteron | |
| L01BC01 | Cytarabin | |
| L01XY01 | Cytarabin und Daunorubicin | |
| L01EC02 | Dabrafenib | |
| L01AX04 | Dacarbazin | |
| L04AC01 | Daclizumab | |
| L01EB07 | Dacomitinib | |
| L01DA01 | Dactinomycin | |
| L01XC24 | Daratumumab | ~L01FC01(Reklassifizierung zu CD38-Inhibitoren) |
| B03XA02 | Darbepoetin alfa | |
| L02BB06 | Darolutamid | |
| L01EA02 | Dasatinib | |
| L01DB02 | Daunorubicin | |
| L01BC08 | Decitabin | |
| L02BX02 | Degarelix | |
| L01CC01 | Demecolcin | |
| L01XX29 | Denileukindiftitox | |
| M05BX04 | Denosumab | |
| H02AB02 | Dexamethason | |
| L01CD02 | Docetaxel | |
| L01DB01 | Doxorubicin | |
| L01XC28 | Durvalumab | ~L01FF03(Reklassifizierung zu PD-1-/PD-L1-Inhibitoren) |
| G04CB02 | Dutasterid | |
| L01EM04 | Duvelisib | |
| L04AA25 | Eculizumab | |
| L04AA21 | Efalizumab | |
| L01XD06 | Efaproxiral | |
| B02BX05 | Eltrombopag | |
| L01XX59 | Enasidenib | |
| L01EC03 | Encorafenib | |
| L01EX14 | Entrectinib | |
| L02BB04 | Enzalutamid | |
| L01DB03 | Epirubicin | |
| L01XX41 | Eribulin | |
| L01EB02 | Erlotinib | |
| B03XA01 | Erythropoietin | |
| L01XX11 | Estramustin | |
| L04AB01 | Etanercept | |
| M05BA01 | Etidronsäure | |
| L01AG01 | Etoglucid | |
| L01CB01 | Etoposid | |
| L01EG02 | Everolimus | |
| L02BG06 | Exemestan | |
| L01EJ02 | Fedratinib | |
| L03AA02 | Filgrastim | |
| G04CB01 | Finasterid | |
| L04AA27 | Fingolimod | |
| L01BC09 | Floxuridin | |
| L01BB05 | Fludarabin | |
| L01BC02 | Fluorouracil | |
| L01BC52 | Fluorouracil, Kombinationen | |
| L02BB01 | Flutamid | |
| V03AF03 | Calciumfolinat | |
| L02BG02 | Formestan | |
| L02AA04 | Fosfestrol | |
| B02BX09 | Fostamatinib | |
| L01AD05 | Fotemustin | |
| L02BA03 | Fulvestrant | |
| L01EB01 | Gefitinib | |
| L01BC05 | Gemcitabin | |
| L02AB03 | Gestonoron | |
| L01EX13 | Gilteritinib | |
| L01XJ03 | Glasdegib | |
| L04AB06 | Golimumab | |
| H01CA01 | Gonadorelin | |
| L02AE03 | Goserelin | |
| L04AA19 | Gusperimus | |
| L03AX14 | Histamindihydrochlorid | |
| L02AE05 | Histrelin | |
| L01XX05 | Hydroxycarbamid | |
| M05BA06 | Ibandronsäure | |
| V10XX02 | (90Y)Ibritumomabtiuxetan | |
| L01EL01 | Ibrutinib | |
| L01DB06 | Idarubicin | |
| L01EM01 | Idelalisib | |
| L01AA06 | Ifosfamid | |
| L01EA01 | Imatinib | |
| D06BB10 | Imiquimod | |
| L04AB02 | Infliximab | |
| D06BX02 | Ingenolmebutat | |
| L01XC26 | Inotuzumab ozogamicin | ~L01FB01(Reklassifizierung zu CD22-Inhibitoren) |
| L03AB01 | Interferon alfa, natürlich | |
| L03AB04 | Interferon alfa-2a | |
| L03AB05 | Interferon alfa-2b | |
| L03AB18 | Interferon gamma-1b | |
| L01XC11 | Ipilimumab | ~L01FX04(Reklassifizierung zu andere monoklonale Antikörper) |
| L01CE02 | Irinotecan | |
| L01XX62 | Ivosidenib | |
| L01DC04 | Ixabepilon | |
| L01XG03 | Ixazomib | |
| H02CA03 | Ketoconazol | |
| H01CB03 | Lanreotid | |
| L01EH01 | Lapatinib | |
| L01EX12 | Larotrectinib | |
| L04AA13 | Leflunomid | |
| L04AX04 | Lenalidomid | |
| L03AA10 | Lenograstim | |
| L01EX08 | Lenvatinib | |
| L02BG04 | Letrozol | |
| L02AE02 | Leuprorelin | |
| L03AA14 | Lipegfilgrastim | |
| L01AD02 | Lomustin | |
| L01XX07 | Lonidamin | |
| L01ED05 | Lorlatinib | |
| B03XA06 | Luspatercept | |
| G03DC03 | Lynestrenol | |
| L01AB03 | Mannosulfan | |
| J05AX09 | Maraviroc | |
| L01XX10 | Masoprocol | |
| L02AB02 | Medroxyprogesteron | |
| L02AB01 | Megestrol | |
| L01AA03 | Melphalan | |
| R03DX09 | Mepolizumab | |
| L01BB02 | Mercaptopurin | |
| V03AF01 | Mesna | |
| N07BC02 | Methadon | |
| L01BA01 | Methotrexat | |
| L01XD10 | Methoxsalen | |
| B03XA03 | Methoxy-Polyethylenglycol-Epoetin beta | |
| L01XD03 | Methylaminolevulinat | |
| H02AB04 | Methylprednisolon | |
| L01EX10 | Midostaurin | |
| L03AX15 | Mifamurtid | |
| L01XX09 | Miltefosin | |
| L01CH01 | Mistelkraut | |
| L01CP01 | Mistelkraut | |
| L01AX01 | Mitobronitol | |
| L01XX16 | Mitoguazon | |
| L01DC03 | Mitomycin | |
| L01XX23 | Mitotan | |
| L01DB07 | Mitoxantron | |
| L03AA03 | Molgramostim | |
| L04AA02 | Muromonab-CD3 | |
| L04AA06 | Mycophenolsäure | |
| L04AA23 | Natalizumab | |
| V03AF10 | Natriumlevofolinat | |
| L01BB07 | Nelarabin | |
| L01EH02 | Neratinib | |
| L01EA03 | Nilotinib | |
| L02BB02 | Nilutamid | |
| L01AD06 | Nimustin | |
| L01EX09 | Nintedanib | |
| L01XK02 | Niraparib | |
| L01XC17 | Nivolumab | ~L01FF01(Reklassifizierung zu PD-1-/PD-L1-Inhibitoren) |
| L01XC15 | Obinutuzumab | ~L01FA03(Reklassifizierung zu CD20-Inhibitoren) |
| L01XX36 | Oblimersen | |
| H01CB02 | Octreotid | |
| L01XK01 | Olaparib | |
| L01XC27 | Olaratumab | ~L01FX10(Reklassifizierung zu andere monoklonale Antikörper) |
| L01XX40 | Omacetaxinmepesuccinat | |
| L03AC02 | Oprelvekin | |
| L01EB04 | Osimertinib | |
| L01XA03 | Oxaliplatin | |
| L01CD01 | Paclitaxel | |
| L01CD03 | Paclitaxelpoliglumex | |
| L01EF01 | Palbociclib | |
| V03AF08 | Palifermin | |
| M05BA03 | Pamidronsäure | |
| L01XC08 | Panitumumab | ~L01FE02(Reklassifizierung zu EGFR-Inhibitoren) |
| L01XH03 | Panobinostat | |
| L01EX03 | Pazopanib | |
| L01XX24 | Pegaspargase | |
| L03AA13 | Pegfilgrastim | |
| L03AB11 | Peginterferon alfa-2a | |
| L03AB10 | Peginterferon alfa-2b | |
| L01XC18 | Pembrolizumab | ~L01FF02(Reklassifizierung zu PD-1-/PD-L1-Inhibitoren) |
| L01BA04 | Pemetrexed | |
| L01XX08 | Pentostatin | |
| L01XC13 | Pertuzumab | ~L01FD02(Reklassifizierung zu HER2-Inhibitoren) |
| L01AX02 | Pipobroman | |
| L01DB08 | Pirarubicin | |
| L01DB11 | Pixantron | |
| V03AX10 | Placebo | |
| L03AX16 | Plerixafor | |
| L01DC02 | Plicamycin | |
| L03AX08 | Poly ICLC | |
| L02AA02 | Polyestradiolphosphat | |
| L01XA05 | Polyplatillen | |
| L04AX06 | Pomalidomid | |
| L01EA05 | Ponatinib | |
| L01XD01 | Porfimer natrium | |
| L01BA05 | Pralatrexat | |
| D07AC18 | Prednicarbat | |
| L01AA08 | Prednimustin | |
| H02AB06 | Prednisolon | |
| H02AB07 | Prednison | |
| L01XB01 | Procarbazin | |
| D05AD | Psoralene zur topischen Anwendung | |
| D05BA | Psoralene zur systemischen Anwendung | |
| L01EX11 | Quizartinib | |
| G03XC01 | Raloxifen | |
| L01BA03 | Raltitrexed | |
| L01XC21 | Ramucirumab | ~L01FG02(Reklassifizierung zu VEGF-/VEGFR-Inhibitoren) |
| L01AD07 | Ranimustin | |
| L01EX05 | Regorafenib | |
| L01EF02 | Ribociclib | |
| L04AC04 | Rilonacept | |
| L01EX19 | Ripretinib | |
| M05BA07 | Risedronsäure | |
| L01XC02 | Rituximab | ~L01FA01(Reklassifizierung zu CD20-Inhibitoren) |
| L01XH02 | Romidepsin | |
| B02BX04 | Romiplostim | |
| L03AB15 | Ropeginterferon alfa-2b | |
| L01XK03 | Rucaparib | |
| L01EJ01 | Ruxolitinib | |
| L01XA04 | Satraplatin | |
| L01XX66 | Selinexor | |
| L01EE04 | Selumetinib | |
| L01AD03 | Semustin | |
| L04AC11 | Siltuximab | |
| L04AA10 | Sirolimus | |
| H01CB01 | Somatostatin | |
| L01XJ02 | Sonidegib | |
| L01EX02 | Sorafenib | |
| L01AD04 | Streptozocin | |
| L01EX01 | Sunitinib | |
| L04AD02 | Tacrolimus | |
| L01XX67 | Tagraxofusp | |
| L01XK04 | Talazoparib | |
| L01XX51 | Talimogen laherparepvec | |
| L02BA01 | Tamoxifen | |
| L03AX11 | Tasonermin | |
| L01BC53 | Tegafur, Kombinationen | |
| L01BC63 | Tegafur und Uracil | |
| L01BC73 | Tegafur, Gimeracil und Oteracil | |
| L01XD05 | Temoporfin | |
| L01AX03 | Temozolomid | |
| L01EG01 | Temsirolimus | |
| L01CB02 | Teniposid | |
| L01EX21 | Tepotinib | |
| L04AX02 | Thalidomid | |
| L01AC01 | Thiotepa | |
| L01XX18 | Tiazofurin | |
| M05BA05 | Tiludronsäure | |
| L01BB03 | Tioguanin | |
| L01XX71 | Tisagenlecleucel | |
| L01EK03 | Tivozanib | |
| L04AC07 | Tocilizumab | |
| L01CE01 | Topotecan | |
| L02BA02 | Toremifen | |
| V10XA53 | Tositumomab/(131I)Iodtositumomab | |
| L01CX01 | Trabectedin | |
| L01EE01 | Trametinib | |
| L01XC03 | Trastuzumab | ~L01FD01(Reklassifizierung zu HER2-Inhibitoren) |
| L01XC14 | Trastuzumab emtansin | ~L01FD03(Reklassifizierung zu HER2-Inhibitoren) |
| L01AB02 | Treosulfan | |
| L01XF01 | Tretinoin | |
| L01AC02 | Triaziquon | |
| L01BC59 | Trifluridin, Kombinationen | |
| L02AE04 | Triptorelin | |
| L01AA07 | Trofosfamid | |
| L01EH03 | Tucatinib | |
| L01AD08 | Uramustin | |
| N03AG01 | Valproinsäure | |
| L01DB09 | Valrubicin | |
| L01EX04 | Vandetanib | |
| L01XK05 | Veliparib | |
| L01EC01 | Vemurafenib | |
| L01XX52 | Venetoclax | |
| L01CA01 | Vinblastin | |
| L01CA02 | Vincristin | |
| L01CA03 | Vindesin | |
| L01CA05 | Vinflunin | |
| L01CA04 | Vinorelbin | |
| L01XJ01 | Vismodegib | |
| L04AD03 | Voclosporin | |
| L01XH01 | Vorinostat | |
| L02BG05 | Vorozol | |
| L01XX53 | Vosaroxin | |
| L01EL03 | Zanubrutinib | |
| M05BA08 | Zoledronsäure | |
| L01DB05 | Zorubicin |
{
"resourceType": "ValueSet",
"id": "mii-vs-onko-systemische-therapie-substanzen-2021",
"meta": {
"extension": [
{
"url": "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-license",
"valueCode": "CC-BY-4.0"
},
{
"extension": [
{
"url": "packageId",
"valueId": "de.medizininformatikinitiative.kerndatensatz.onkologie"
},
{
"url": "version",
"valueString": "2027.0.0-ballot.1"
},
{
"url": "uri",
"valueUri": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/package-source"
}
],
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablevalueset",
"http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablevalueset",
"http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-computablevalueset"
]
},
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability",
"valueCode": "shareable"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability",
"valueCode": "publishable"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability",
"valueCode": "computable"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-versionPolicy",
"valueCodeableConcept": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/artifact-version-policy-codes",
"code": "package",
"display": "Package"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-approvalDate",
"valueDate": "2026-09-15"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-topic",
"valueCodeableConcept": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C3262"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-author",
"valueContactDetail": {
"telecom": [
{
"system": "email",
"value": "thomas.debertshaeuser@charite.de"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-editor",
"valueContactDetail": {
"name": "Taskforce Core Data Set"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-reviewer",
"valueContactDetail": {
"name": "Interoperability Working Group",
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de/en/collaboration/interoperability-working-group"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-reviewer",
"valueContactDetail": {
"name": "National Steering Committee",
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de/en/collaboration/national-steering-committee"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-endorser",
"valueContactDetail": {
"name": "Interoperability Working Group",
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de/en/collaboration/interoperability-working-group"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-endorser",
"valueContactDetail": {
"name": "National Steering Committee",
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de/en/collaboration/national-steering-committee"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-versionAlgorithm",
"valueCoding": {
"system": "http://hl7.org/fhir/version-algorithm",
"code": "semver",
"display": "SemVer"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-effectivePeriod",
"valuePeriod": {
"start": "2027"
}
}
],
"url": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-systemische-therapie-substanzen-2021",
"version": "2027.0.0-ballot.1",
"name": "MII_VS_Onko_Systemische_Therapie_Substanzen_2021",
"title": "MII VS Onkologie Systemische Therapie Substanzen ATC 2021",
"status": "active",
"experimental": false,
"date": "2026-09-15T06:26:59+00:00",
"publisher": "Medizininformatik Initiative",
"contact": [
{
"name": "Medizininformatik Initiative",
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de/"
}
]
}
],
"description": "ATC-Codes für Substanzen der systemischen Therapie, validiert gegen ATC-DE Version 2021. Für historische Datenvalidierung.",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "DE",
"display": "Germany"
}
]
}
],
"compose": {
"include": [
{
"system": "http://fhir.de/CodeSystem/bfarm/atc",
"version": "2021",
"concept": [
{
"code": "L02BX01",
"display": "Abarelix"
},
{
"code": "L04AA24",
"display": "Abatacept"
},
{
"code": "L01EF03",
"display": "Abemaciclib"
},
{
"code": "L04AA22",
"display": "Abetimus"
},
{
"code": "L02BX03",
"display": "Abirateron"
},
{
"code": "L01EL02",
"display": "Acalabrutinib"
},
{
"code": "L01DB04",
"display": "Aclarubicin"
},
{
"code": "L04AB04",
"display": "Adalimumab"
},
{
"code": "L01EB03",
"display": "Afatinib"
},
{
"code": "L04AB03",
"display": "Afelimomab"
},
{
"code": "L01XX44",
"display": "Aflibercept"
},
{
"code": "L03AC01",
"display": "Aldesleukin"
},
{
"code": "L01ED03",
"display": "Alectinib"
},
{
"code": "L04AA15",
"display": "Alefacept"
},
{
"code": "L04AA34",
"display": "Alemtuzumab"
},
{
"code": "M05BA04",
"display": "Alendronsäure"
},
{
"code": "L01XF02",
"display": "Alitretinoin"
},
{
"code": "L01EM03",
"display": "Alpelisib"
},
{
"code": "L01XX03",
"display": "Altretamin"
},
{
"code": "V03AM01",
"display": "Amilomer"
},
{
"code": "L02BG01",
"display": "Aminoglutethimid"
},
{
"code": "L01XD04",
"display": "Aminolevulinsäure"
},
{
"code": "L01DB10",
"display": "Amrubicin"
},
{
"code": "L01XX01",
"display": "Amsacrin"
},
{
"code": "L01XX35",
"display": "Anagrelid"
},
{
"code": "L04AC03",
"display": "Anakinra"
},
{
"code": "L02BG03",
"display": "Anastrozol"
},
{
"code": "L04AA04",
"display": "Antithymozytäres Immunglobulin (Kaninchen)"
},
{
"code": "L02BB05",
"display": "Apalutamid"
},
{
"code": "L01XX27",
"display": "Arsentrioxid"
},
{
"code": "P01BE03",
"display": "Artesunat"
},
{
"code": "L01XX02",
"display": "Asparaginase"
},
{
"code": "L01XC32",
"display": "Atezolizumab"
},
{
"code": "L01EX18",
"display": "Avapritinib"
},
{
"code": "L01XC31",
"display": "Avelumab"
},
{
"code": "L01XX70",
"display": "Axicabtagen Ciloleucel"
},
{
"code": "L01EK01",
"display": "Axitinib"
},
{
"code": "L01BC07",
"display": "Azacitidin"
},
{
"code": "L04AX01",
"display": "Azathioprin"
},
{
"code": "L04AC02",
"display": "Basiliximab"
},
{
"code": "L03AX03",
"display": "BCG-Impfstoff"
},
{
"code": "L04AA28",
"display": "Belatacept"
},
{
"code": "L04AA26",
"display": "Belimumab"
},
{
"code": "L01XH04",
"display": "Belinostat"
},
{
"code": "L01AA09",
"display": "Bendamustin"
},
{
"code": "L01XC07",
"display": "Bevacizumab"
},
{
"code": "L01XF03",
"display": "Bexaroten"
},
{
"code": "L02BB03",
"display": "Bicalutamid"
},
{
"code": "L01EE03",
"display": "Binimetinib"
},
{
"code": "L01DC01",
"display": "Bleomycin"
},
{
"code": "L01XC19",
"display": "Blinatumomab"
},
{
"code": "L01XG01",
"display": "Bortezomib"
},
{
"code": "L01EA04",
"display": "Bosutinib"
},
{
"code": "L01XC12",
"display": "Brentuximab vedotin"
},
{
"code": "L04AC09",
"display": "Briakinumab"
},
{
"code": "L01ED04",
"display": "Brigatinib"
},
{
"code": "N04BC01",
"display": "Bromocriptin"
},
{
"code": "L02AE01",
"display": "Buserelin"
},
{
"code": "L01AB01",
"display": "Busulfan"
},
{
"code": "L01CD04",
"display": "Cabazitaxel"
},
{
"code": "N04BC06",
"display": "Cabergolin"
},
{
"code": "L01EX07",
"display": "Cabozantinib"
},
{
"code": "V03AF04",
"display": "Calciumlevofolinat"
},
{
"code": "L04AC08",
"display": "Canakinumab"
},
{
"code": "L01BC06",
"display": "Capecitabin"
},
{
"code": "L01EX17",
"display": "Capmatinib"
},
{
"code": "L01XA02",
"display": "Carboplatin"
},
{
"code": "L01AC03",
"display": "Carboquon"
},
{
"code": "L01XG02",
"display": "Carfilzomib"
},
{
"code": "L01BC04",
"display": "Carmofur"
},
{
"code": "L01AD01",
"display": "Carmustin"
},
{
"code": "L01ED02",
"display": "Ceritinib"
},
{
"code": "L04AB05",
"display": "Certolizumab pegol"
},
{
"code": "H01CC02",
"display": "Cetrorelix"
},
{
"code": "L01XC06",
"display": "Cetuximab"
},
{
"code": "L01AA02",
"display": "Chlorambucil"
},
{
"code": "G03DB06",
"display": "Chlormadinon"
},
{
"code": "L01AA05",
"display": "Chlormethin"
},
{
"code": "L04AD01",
"display": "Ciclosporin"
},
{
"code": "L01XA01",
"display": "Cisplatin"
},
{
"code": "L01BB04",
"display": "Cladribin"
},
{
"code": "M05BA02",
"display": "Clodronsäure"
},
{
"code": "L01BB06",
"display": "Clofarabin"
},
{
"code": "L01EE02",
"display": "Cobimetinib"
},
{
"code": "L01EM02",
"display": "Copanlisib"
},
{
"code": "L01ED01",
"display": "Crizotinib"
},
{
"code": "L01AA01",
"display": "Cyclophosphamid"
},
{
"code": "G03HA01",
"display": "Cyproteron"
},
{
"code": "L01BC01",
"display": "Cytarabin"
},
{
"code": "L01XY01",
"display": "Cytarabin und Daunorubicin"
},
{
"code": "L01EC02",
"display": "Dabrafenib"
},
{
"code": "L01AX04",
"display": "Dacarbazin"
},
{
"code": "L04AC01",
"display": "Daclizumab"
},
{
"code": "L01EB07",
"display": "Dacomitinib"
},
{
"code": "L01DA01",
"display": "Dactinomycin"
},
{
"code": "L01XC24",
"display": "Daratumumab"
},
{
"code": "B03XA02",
"display": "Darbepoetin alfa"
},
{
"code": "L02BB06",
"display": "Darolutamid"
},
{
"code": "L01EA02",
"display": "Dasatinib"
},
{
"code": "L01DB02",
"display": "Daunorubicin"
},
{
"code": "L01BC08",
"display": "Decitabin"
},
{
"code": "L02BX02",
"display": "Degarelix"
},
{
"code": "L01CC01",
"display": "Demecolcin"
},
{
"code": "L01XX29",
"display": "Denileukindiftitox"
},
{
"code": "M05BX04",
"display": "Denosumab"
},
{
"code": "H02AB02",
"display": "Dexamethason"
},
{
"code": "L01CD02",
"display": "Docetaxel"
},
{
"code": "L01DB01",
"display": "Doxorubicin"
},
{
"code": "L01XC28",
"display": "Durvalumab"
},
{
"code": "G04CB02",
"display": "Dutasterid"
},
{
"code": "L01EM04",
"display": "Duvelisib"
},
{
"code": "L04AA25",
"display": "Eculizumab"
},
{
"code": "L04AA21",
"display": "Efalizumab"
},
{
"code": "L01XD06",
"display": "Efaproxiral"
},
{
"code": "B02BX05",
"display": "Eltrombopag"
},
{
"code": "L01XX59",
"display": "Enasidenib"
},
{
"code": "L01EC03",
"display": "Encorafenib"
},
{
"code": "L01EX14",
"display": "Entrectinib"
},
{
"code": "L02BB04",
"display": "Enzalutamid"
},
{
"code": "L01DB03",
"display": "Epirubicin"
},
{
"code": "L01XX41",
"display": "Eribulin"
},
{
"code": "L01EB02",
"display": "Erlotinib"
},
{
"code": "B03XA01",
"display": "Erythropoietin"
},
{
"code": "L01XX11",
"display": "Estramustin"
},
{
"code": "L04AB01",
"display": "Etanercept"
},
{
"code": "M05BA01",
"display": "Etidronsäure"
},
{
"code": "L01AG01",
"display": "Etoglucid"
},
{
"code": "L01CB01",
"display": "Etoposid"
},
{
"code": "L01EG02",
"display": "Everolimus"
},
{
"code": "L02BG06",
"display": "Exemestan"
},
{
"code": "L01EJ02",
"display": "Fedratinib"
},
{
"code": "L03AA02",
"display": "Filgrastim"
},
{
"code": "G04CB01",
"display": "Finasterid"
},
{
"code": "L04AA27",
"display": "Fingolimod"
},
{
"code": "L01BC09",
"display": "Floxuridin"
},
{
"code": "L01BB05",
"display": "Fludarabin"
},
{
"code": "L01BC02",
"display": "Fluorouracil"
},
{
"code": "L01BC52",
"display": "Fluorouracil, Kombinationen"
},
{
"code": "L02BB01",
"display": "Flutamid"
},
{
"code": "V03AF03",
"display": "Calciumfolinat"
},
{
"code": "L02BG02",
"display": "Formestan"
},
{
"code": "L02AA04",
"display": "Fosfestrol"
},
{
"code": "B02BX09",
"display": "Fostamatinib"
},
{
"code": "L01AD05",
"display": "Fotemustin"
},
{
"code": "L02BA03",
"display": "Fulvestrant"
},
{
"code": "L01EB01",
"display": "Gefitinib"
},
{
"code": "L01BC05",
"display": "Gemcitabin"
},
{
"code": "L02AB03",
"display": "Gestonoron"
},
{
"code": "L01EX13",
"display": "Gilteritinib"
},
{
"code": "L01XJ03",
"display": "Glasdegib"
},
{
"code": "L04AB06",
"display": "Golimumab"
},
{
"code": "H01CA01",
"display": "Gonadorelin"
},
{
"code": "L02AE03",
"display": "Goserelin"
},
{
"code": "L04AA19",
"display": "Gusperimus"
},
{
"code": "L03AX14",
"display": "Histamindihydrochlorid"
},
{
"code": "L02AE05",
"display": "Histrelin"
},
{
"code": "L01XX05",
"display": "Hydroxycarbamid"
},
{
"code": "M05BA06",
"display": "Ibandronsäure"
},
{
"code": "V10XX02",
"display": "(90Y)Ibritumomabtiuxetan"
},
{
"code": "L01EL01",
"display": "Ibrutinib"
},
{
"code": "L01DB06",
"display": "Idarubicin"
},
{
"code": "L01EM01",
"display": "Idelalisib"
},
{
"code": "L01AA06",
"display": "Ifosfamid"
},
{
"code": "L01EA01",
"display": "Imatinib"
},
{
"code": "D06BB10",
"display": "Imiquimod"
},
{
"code": "L04AB02",
"display": "Infliximab"
},
{
"code": "D06BX02",
"display": "Ingenolmebutat"
},
{
"code": "L01XC26",
"display": "Inotuzumab ozogamicin"
},
{
"code": "L03AB01",
"display": "Interferon alfa, natürlich"
},
{
"code": "L03AB04",
"display": "Interferon alfa-2a"
},
{
"code": "L03AB05",
"display": "Interferon alfa-2b"
},
{
"code": "L03AB18",
"display": "Interferon gamma-1b"
},
{
"code": "L01XC11",
"display": "Ipilimumab"
},
{
"code": "L01CE02",
"display": "Irinotecan"
},
{
"code": "L01XX62",
"display": "Ivosidenib"
},
{
"code": "L01DC04",
"display": "Ixabepilon"
},
{
"code": "L01XG03",
"display": "Ixazomib"
},
{
"code": "H02CA03",
"display": "Ketoconazol"
},
{
"code": "H01CB03",
"display": "Lanreotid"
},
{
"code": "L01EH01",
"display": "Lapatinib"
},
{
"code": "L01EX12",
"display": "Larotrectinib"
},
{
"code": "L04AA13",
"display": "Leflunomid"
},
{
"code": "L04AX04",
"display": "Lenalidomid"
},
{
"code": "L03AA10",
"display": "Lenograstim"
},
{
"code": "L01EX08",
"display": "Lenvatinib"
},
{
"code": "L02BG04",
"display": "Letrozol"
},
{
"code": "L02AE02",
"display": "Leuprorelin"
},
{
"code": "L03AA14",
"display": "Lipegfilgrastim"
},
{
"code": "L01AD02",
"display": "Lomustin"
},
{
"code": "L01XX07",
"display": "Lonidamin"
},
{
"code": "L01ED05",
"display": "Lorlatinib"
},
{
"code": "B03XA06",
"display": "Luspatercept"
},
{
"code": "G03DC03",
"display": "Lynestrenol"
},
{
"code": "L01AB03",
"display": "Mannosulfan"
},
{
"code": "J05AX09",
"display": "Maraviroc"
},
{
"code": "L01XX10",
"display": "Masoprocol"
},
{
"code": "L02AB02",
"display": "Medroxyprogesteron"
},
{
"code": "L02AB01",
"display": "Megestrol"
},
{
"code": "L01AA03",
"display": "Melphalan"
},
{
"code": "R03DX09",
"display": "Mepolizumab"
},
{
"code": "L01BB02",
"display": "Mercaptopurin"
},
{
"code": "V03AF01",
"display": "Mesna"
},
{
"code": "N07BC02",
"display": "Methadon"
},
{
"code": "L01BA01",
"display": "Methotrexat"
},
{
"code": "L01XD10",
"display": "Methoxsalen"
},
{
"code": "B03XA03",
"display": "Methoxy-Polyethylenglycol-Epoetin beta"
},
{
"code": "L01XD03",
"display": "Methylaminolevulinat"
},
{
"code": "H02AB04",
"display": "Methylprednisolon"
},
{
"code": "L01EX10",
"display": "Midostaurin"
},
{
"code": "L03AX15",
"display": "Mifamurtid"
},
{
"code": "L01XX09",
"display": "Miltefosin"
},
{
"code": "L01CH01",
"display": "Mistelkraut"
},
{
"code": "L01CP01",
"display": "Mistelkraut"
},
{
"code": "L01AX01",
"display": "Mitobronitol"
},
{
"code": "L01XX16",
"display": "Mitoguazon"
},
{
"code": "L01DC03",
"display": "Mitomycin"
},
{
"code": "L01XX23",
"display": "Mitotan"
},
{
"code": "L01DB07",
"display": "Mitoxantron"
},
{
"code": "L03AA03",
"display": "Molgramostim"
},
{
"code": "L04AA02",
"display": "Muromonab-CD3"
},
{
"code": "L04AA06",
"display": "Mycophenolsäure"
},
{
"code": "L04AA23",
"display": "Natalizumab"
},
{
"code": "V03AF10",
"display": "Natriumlevofolinat"
},
{
"code": "L01BB07",
"display": "Nelarabin"
},
{
"code": "L01EH02",
"display": "Neratinib"
},
{
"code": "L01EA03",
"display": "Nilotinib"
},
{
"code": "L02BB02",
"display": "Nilutamid"
},
{
"code": "L01AD06",
"display": "Nimustin"
},
{
"code": "L01EX09",
"display": "Nintedanib"
},
{
"code": "L01XK02",
"display": "Niraparib"
},
{
"code": "L01XC17",
"display": "Nivolumab"
},
{
"code": "L01XC15",
"display": "Obinutuzumab"
},
{
"code": "L01XX36",
"display": "Oblimersen"
},
{
"code": "H01CB02",
"display": "Octreotid"
},
{
"code": "L01XK01",
"display": "Olaparib"
},
{
"code": "L01XC27",
"display": "Olaratumab"
},
{
"code": "L01XX40",
"display": "Omacetaxinmepesuccinat"
},
{
"code": "L03AC02",
"display": "Oprelvekin"
},
{
"code": "L01EB04",
"display": "Osimertinib"
},
{
"code": "L01XA03",
"display": "Oxaliplatin"
},
{
"code": "L01CD01",
"display": "Paclitaxel"
},
{
"code": "L01CD03",
"display": "Paclitaxelpoliglumex"
},
{
"code": "L01EF01",
"display": "Palbociclib"
},
{
"code": "V03AF08",
"display": "Palifermin"
},
{
"code": "M05BA03",
"display": "Pamidronsäure"
},
{
"code": "L01XC08",
"display": "Panitumumab"
},
{
"code": "L01XH03",
"display": "Panobinostat"
},
{
"code": "L01EX03",
"display": "Pazopanib"
},
{
"code": "L01XX24",
"display": "Pegaspargase"
},
{
"code": "L03AA13",
"display": "Pegfilgrastim"
},
{
"code": "L03AB11",
"display": "Peginterferon alfa-2a"
},
{
"code": "L03AB10",
"display": "Peginterferon alfa-2b"
},
{
"code": "L01XC18",
"display": "Pembrolizumab"
},
{
"code": "L01BA04",
"display": "Pemetrexed"
},
{
"code": "L01XX08",
"display": "Pentostatin"
},
{
"code": "L01XC13",
"display": "Pertuzumab"
},
{
"code": "L01AX02",
"display": "Pipobroman"
},
{
"code": "L01DB08",
"display": "Pirarubicin"
},
{
"code": "L01DB11",
"display": "Pixantron"
},
{
"code": "V03AX10",
"display": "Placebo"
},
{
"code": "L03AX16",
"display": "Plerixafor"
},
{
"code": "L01DC02",
"display": "Plicamycin"
},
{
"code": "L03AX08",
"display": "Poly ICLC"
},
{
"code": "L02AA02",
"display": "Polyestradiolphosphat"
},
{
"code": "L01XA05",
"display": "Polyplatillen"
},
{
"code": "L04AX06",
"display": "Pomalidomid"
},
{
"code": "L01EA05",
"display": "Ponatinib"
},
{
"code": "L01XD01",
"display": "Porfimer natrium"
},
{
"code": "L01BA05",
"display": "Pralatrexat"
},
{
"code": "D07AC18",
"display": "Prednicarbat"
},
{
"code": "L01AA08",
"display": "Prednimustin"
},
{
"code": "H02AB06",
"display": "Prednisolon"
},
{
"code": "H02AB07",
"display": "Prednison"
},
{
"code": "L01XB01",
"display": "Procarbazin"
},
{
"code": "D05AD",
"display": "Psoralene zur topischen Anwendung"
},
{
"code": "D05BA",
"display": "Psoralene zur systemischen Anwendung"
},
{
"code": "L01EX11",
"display": "Quizartinib"
},
{
"code": "G03XC01",
"display": "Raloxifen"
},
{
"code": "L01BA03",
"display": "Raltitrexed"
},
{
"code": "L01XC21",
"display": "Ramucirumab"
},
{
"code": "L01AD07",
"display": "Ranimustin"
},
{
"code": "L01EX05",
"display": "Regorafenib"
},
{
"code": "L01EF02",
"display": "Ribociclib"
},
{
"code": "L04AC04",
"display": "Rilonacept"
},
{
"code": "L01EX19",
"display": "Ripretinib"
},
{
"code": "M05BA07",
"display": "Risedronsäure"
},
{
"code": "L01XC02",
"display": "Rituximab"
},
{
"code": "L01XH02",
"display": "Romidepsin"
},
{
"code": "B02BX04",
"display": "Romiplostim"
},
{
"code": "L03AB15",
"display": "Ropeginterferon alfa-2b"
},
{
"code": "L01XK03",
"display": "Rucaparib"
},
{
"code": "L01EJ01",
"display": "Ruxolitinib"
},
{
"code": "L01XA04",
"display": "Satraplatin"
},
{
"code": "L01XX66",
"display": "Selinexor"
},
{
"code": "L01EE04",
"display": "Selumetinib"
},
{
"code": "L01AD03",
"display": "Semustin"
},
{
"code": "L04AC11",
"display": "Siltuximab"
},
{
"code": "L04AA10",
"display": "Sirolimus"
},
{
"code": "H01CB01",
"display": "Somatostatin"
},
{
"code": "L01XJ02",
"display": "Sonidegib"
},
{
"code": "L01EX02",
"display": "Sorafenib"
},
{
"code": "L01AD04",
"display": "Streptozocin"
},
{
"code": "L01EX01",
"display": "Sunitinib"
},
{
"code": "L04AD02",
"display": "Tacrolimus"
},
{
"code": "L01XX67",
"display": "Tagraxofusp"
},
{
"code": "L01XK04",
"display": "Talazoparib"
},
{
"code": "L01XX51",
"display": "Talimogen laherparepvec"
},
{
"code": "L02BA01",
"display": "Tamoxifen"
},
{
"code": "L03AX11",
"display": "Tasonermin"
},
{
"code": "L01BC53",
"display": "Tegafur, Kombinationen"
},
{
"code": "L01BC63",
"display": "Tegafur und Uracil"
},
{
"code": "L01BC73",
"display": "Tegafur, Gimeracil und Oteracil"
},
{
"code": "L01XD05",
"display": "Temoporfin"
},
{
"code": "L01AX03",
"display": "Temozolomid"
},
{
"code": "L01EG01",
"display": "Temsirolimus"
},
{
"code": "L01CB02",
"display": "Teniposid"
},
{
"code": "L01EX21",
"display": "Tepotinib"
},
{
"code": "L04AX02",
"display": "Thalidomid"
},
{
"code": "L01AC01",
"display": "Thiotepa"
},
{
"code": "L01XX18",
"display": "Tiazofurin"
},
{
"code": "M05BA05",
"display": "Tiludronsäure"
},
{
"code": "L01BB03",
"display": "Tioguanin"
},
{
"code": "L01XX71",
"display": "Tisagenlecleucel"
},
{
"code": "L01EK03",
"display": "Tivozanib"
},
{
"code": "L04AC07",
"display": "Tocilizumab"
},
{
"code": "L01CE01",
"display": "Topotecan"
},
{
"code": "L02BA02",
"display": "Toremifen"
},
{
"code": "V10XA53",
"display": "Tositumomab/(131I)Iodtositumomab"
},
{
"code": "L01CX01",
"display": "Trabectedin"
},
{
"code": "L01EE01",
"display": "Trametinib"
},
{
"code": "L01XC03",
"display": "Trastuzumab"
},
{
"code": "L01XC14",
"display": "Trastuzumab emtansin"
},
{
"code": "L01AB02",
"display": "Treosulfan"
},
{
"code": "L01XF01",
"display": "Tretinoin"
},
{
"code": "L01AC02",
"display": "Triaziquon"
},
{
"code": "L01BC59",
"display": "Trifluridin, Kombinationen"
},
{
"code": "L02AE04",
"display": "Triptorelin"
},
{
"code": "L01AA07",
"display": "Trofosfamid"
},
{
"code": "L01EH03",
"display": "Tucatinib"
},
{
"code": "L01AD08",
"display": "Uramustin"
},
{
"code": "N03AG01",
"display": "Valproinsäure"
},
{
"code": "L01DB09",
"display": "Valrubicin"
},
{
"code": "L01EX04",
"display": "Vandetanib"
},
{
"code": "L01XK05",
"display": "Veliparib"
},
{
"code": "L01EC01",
"display": "Vemurafenib"
},
{
"code": "L01XX52",
"display": "Venetoclax"
},
{
"code": "L01CA01",
"display": "Vinblastin"
},
{
"code": "L01CA02",
"display": "Vincristin"
},
{
"code": "L01CA03",
"display": "Vindesin"
},
{
"code": "L01CA05",
"display": "Vinflunin"
},
{
"code": "L01CA04",
"display": "Vinorelbin"
},
{
"code": "L01XJ01",
"display": "Vismodegib"
},
{
"code": "L04AD03",
"display": "Voclosporin"
},
{
"code": "L01XH01",
"display": "Vorinostat"
},
{
"code": "L02BG05",
"display": "Vorozol"
},
{
"code": "L01XX53",
"display": "Vosaroxin"
},
{
"code": "L01EL03",
"display": "Zanubrutinib"
},
{
"code": "M05BA08",
"display": "Zoledronsäure"
},
{
"code": "L01DB05",
"display": "Zorubicin"
}
]
}
]
}
}